Docusign (NASDAQ:DOCU) Given New $86.00 Price Target at Citizens Jmp

Docusign (NASDAQ:DOCU) had its price target decreased by Citizens Jmp from $124.00 to $86.00 in a research report sent to investors on Wednesday morning,Benzinga reports. Citizens Jmp currently has a market outperform rating on the stock.

Other analysts have also issued reports about the company. Needham & Company LLC reissued a “hold” rating on shares of Docusign in a report on Tuesday, March 10th. Jefferies Financial Group downgraded Docusign from a “buy” rating to a “hold” rating and dropped their price target for the company from $105.00 to $45.00 in a research note on Monday, February 23rd. BTIG Research reaffirmed a “buy” rating and set a $70.00 price objective on shares of Docusign in a research report on Wednesday. HSBC set a $53.00 target price on shares of Docusign in a report on Friday, February 13th. Finally, Citigroup restated a “market outperform” rating on shares of Docusign in a research report on Monday, March 2nd. Five analysts have rated the stock with a Buy rating and sixteen have issued a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $66.67.

Docusign Trading Up 2.9%

Shares of DOCU stock opened at $48.90 on Wednesday. The stock has a market cap of $9.79 billion, a P/E ratio of 33.04, a price-to-earnings-growth ratio of 2.07 and a beta of 1.03. The stock has a 50 day simple moving average of $50.69 and a 200 day simple moving average of $64.35. Docusign has a 1 year low of $40.16 and a 1 year high of $94.67.

Docusign (NASDAQ:DOCU) last issued its quarterly earnings results on Tuesday, March 17th. The company reported $1.01 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.95 by $0.06. Docusign had a return on equity of 16.70% and a net margin of 9.60%.The business had revenue of $836.86 million for the quarter, compared to the consensus estimate of $828.23 million. During the same quarter in the prior year, the business posted $0.86 earnings per share. The firm’s quarterly revenue was up 7.8% compared to the same quarter last year. Analysts forecast that Docusign will post 1.17 EPS for the current year.

Docusign declared that its board has approved a share repurchase program on Tuesday, March 17th that authorizes the company to repurchase $2.00 billion in shares. This repurchase authorization authorizes the company to reacquire up to 21% of its shares through open market purchases. Shares repurchase programs are usually a sign that the company’s management believes its shares are undervalued.

Insider Activity at Docusign

In related news, CEO Allan C. Thygesen sold 26,250 shares of the stock in a transaction that occurred on Friday, January 9th. The shares were sold at an average price of $69.60, for a total value of $1,827,000.00. Following the completion of the transaction, the chief executive officer owned 142,261 shares of the company’s stock, valued at $9,901,365.60. This represents a 15.58% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider James P. Shaughnessy sold 12,000 shares of the firm’s stock in a transaction that occurred on Friday, January 2nd. The shares were sold at an average price of $67.03, for a total transaction of $804,360.00. Following the completion of the sale, the insider owned 54,550 shares in the company, valued at $3,656,486.50. This represents a 18.03% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 51,477 shares of company stock valued at $3,521,607. 1.01% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of DOCU. Norges Bank acquired a new stake in shares of Docusign during the 4th quarter valued at $186,795,000. Capital World Investors grew its position in Docusign by 38.1% during the 4th quarter. Capital World Investors now owns 5,815,804 shares of the company’s stock worth $397,801,000 after acquiring an additional 1,603,900 shares during the last quarter. Woodline Partners LP increased its holdings in Docusign by 24,412.7% in the 3rd quarter. Woodline Partners LP now owns 958,938 shares of the company’s stock worth $69,130,000 after purchasing an additional 955,026 shares in the last quarter. Arrowstreet Capital Limited Partnership increased its holdings in Docusign by 46.1% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 3,001,132 shares of the company’s stock worth $205,277,000 after purchasing an additional 946,512 shares in the last quarter. Finally, Marshall Wace LLP raised its position in Docusign by 1,575.5% in the fourth quarter. Marshall Wace LLP now owns 888,411 shares of the company’s stock valued at $60,767,000 after purchasing an additional 835,388 shares during the last quarter. 77.64% of the stock is currently owned by institutional investors and hedge funds.

Key Stories Impacting Docusign

Here are the key news stories impacting Docusign this week:

• Positive Sentiment: Q4 results and FY27 outlook beat estimates — DocuSign reported adjusted EPS of $1.01 and revenue of $836.9M, topping Street forecasts and signaling continued subscription growth and momentum into fiscal 2027. Docusign’s Q4 Earnings and Revenues Surpass Estimates, Increase Y/Y
• Positive Sentiment: Share‑repurchase boost — Management authorized a $2.0 billion increase to the buyback program, a direct capital‑return action that supports EPS and signals confidence from the board. PR Newswire: Share Repurchase Increase
• Positive Sentiment: Product traction in IAM and AI — Management highlighted strong IAM ARR (> $350M after 18 months) and plans to grow IAM share and AI partnerships, supporting secular expansion beyond e‑signatures. Seeking Alpha: IAM ARR and AI Partnerships
• Neutral Sentiment: Analysts and investors want higher top‑line acceleration — Coverage notes that while results showed traction, many want to see sustained >10% revenue growth before committing, leaving some investors on the sidelines. MSN: Analysts Wait for 10%+ Revenue Growth
• Neutral Sentiment: Some buy ratings remain — BTIG reaffirmed a buy with a $70 target, showing pockets of analyst optimism despite broad caution. Benzinga: BTIG Reaffirms Buy
• Negative Sentiment: Broad downward revisions to price targets — Multiple firms (Citigroup, Morgan Stanley, JPMorgan, UBS, Wells Fargo, RBC, Piper Sandler, Baird, others) cut targets after the print, reflecting concerns about growth runway and execution; that pressure caps upside even with the beat. Blockonomi: Analyst Targets Slashed TickerReport: Citigroup Cut
• Negative Sentiment: Valuation and growth trade‑offs highlighted — Analysts trimmed fair‑value estimates and flagged pricing/AI competition risks, underscoring why some investors remain cautious despite product progress. Yahoo Finance: Valuation and AI Risks

About Docusign

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.